Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Z Leder

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|February 4, 2012
Randomized trial assessing the effects of ergocalciferol administration on circulating FGF23Sherri-Ann M Burnett-Bowie, Benjamin Z Leder, Maria P Henao, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|February 23, 2016
Response to Therapy With Teriparatide, Denosumab, or Both in Postmenopausal Women in the DATA (Denosumab and Teriparatide Administration) Study Randomized Controlled TrialBenjamin Z Leder, Joy N Tsai, Robert M Neer, et al.
The Journal of Clinical Endocrinology and Metabolism|November 14, 2014
Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosisBenjamin Z Leder, Louis St L O'Dea, José R Zanchetta, et al.
The Journal of Clinical Endocrinology and Metabolism|April 30, 2009
Effects of teriparatide retreatment in osteoporotic men and womenJoel S Finkelstein, Jason J Wyland, Benjamin Z Leder, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 2, 2024
Zoledronic acid for hip fracture during initial hospitalizationWuQiang Fan, Xiaoxu Sun, Benjamin Z Leder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2012
Sarcopenia during androgen-deprivation therapy for prostate cancerMatthew R Smith, Fred Saad, Blair Egerdie, et al.
The Journal of Clinical Endocrinology and Metabolism|December 25, 2008
Relation between serum testosterone, serum estradiol, sex hormone-binding globulin, and geometrical measures of adult male proximal femur strengthThomas G Travison, Andre B Araujo, Thomas J Beck, et al.
The Journal of Clinical Endocrinology and Metabolism|January 3, 2020
Delayed Denosumab Injections and Bone Mineral Density Response: An Electronic Health Record-based StudyHouchen Lyu, Sizheng S Zhao, Kazuki Yoshida, et al.
The Journal of Clinical Endocrinology and Metabolism|July 3, 2019
Comparison of Teriparatide and Denosumab in Patients Switching From Long-Term Bisphosphonate UseHouchen Lyu, Sizheng S Zhao, Kazuki Yoshida, et al.
Lancet (London, England)|July 7, 2015
Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trialBenjamin Z Leder, Joy N Tsai, Alexander V Uihlein, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Clinical Journal of the American Society of Nephrology : CJASN|February 4, 2012
Randomized trial assessing the effects of ergocalciferol administration on circulating FGF23Sherri-Ann M Burnett-Bowie, Benjamin Z Leder, Maria P Henao, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|February 23, 2016
Response to Therapy With Teriparatide, Denosumab, or Both in Postmenopausal Women in the DATA (Denosumab and Teriparatide Administration) Study Randomized Controlled TrialBenjamin Z Leder, Joy N Tsai, Robert M Neer, et al.
The Journal of Clinical Endocrinology and Metabolism|November 14, 2014
Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosisBenjamin Z Leder, Louis St L O'Dea, José R Zanchetta, et al.
The Journal of Clinical Endocrinology and Metabolism|April 30, 2009
Effects of teriparatide retreatment in osteoporotic men and womenJoel S Finkelstein, Jason J Wyland, Benjamin Z Leder, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 2, 2024
Zoledronic acid for hip fracture during initial hospitalizationWuQiang Fan, Xiaoxu Sun, Benjamin Z Leder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2012
Sarcopenia during androgen-deprivation therapy for prostate cancerMatthew R Smith, Fred Saad, Blair Egerdie, et al.
The Journal of Clinical Endocrinology and Metabolism|December 25, 2008
Relation between serum testosterone, serum estradiol, sex hormone-binding globulin, and geometrical measures of adult male proximal femur strengthThomas G Travison, Andre B Araujo, Thomas J Beck, et al.
The Journal of Clinical Endocrinology and Metabolism|January 3, 2020
Delayed Denosumab Injections and Bone Mineral Density Response: An Electronic Health Record-based StudyHouchen Lyu, Sizheng S Zhao, Kazuki Yoshida, et al.
The Journal of Clinical Endocrinology and Metabolism|July 3, 2019
Comparison of Teriparatide and Denosumab in Patients Switching From Long-Term Bisphosphonate UseHouchen Lyu, Sizheng S Zhao, Kazuki Yoshida, et al.
Lancet (London, England)|July 7, 2015
Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trialBenjamin Z Leder, Joy N Tsai, Alexander V Uihlein, et al.
Pageof 9